anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BenevolentAI · pitchdeck

BenevolentAI | Investor Presentation Deck | 46 slides

46 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

BenevolentAI | Investor Presentation Deck | 46 slides

BenevolentAI · 2022-10
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 8 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution 3 slides 100% 3/3 slides 100% 3/3 slides · 17 hits
— 0/3 slides
66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides 100% 3/3 slides · 6 hits Market 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Financials 2 slides 100% 2/2 slides 100% 2/2 slides · 7 hits
— 0/2 slides
50% 1/2 slides 50% 1/2 slides 100% 2/2 slides
— 0/2 slides

Slide inventory

46
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
front_matter
Open slide detail
04
The slide combines corporate facts with team and board composition.summarize
Open slide detailBeat · Team
05
show_traction
Open slide detail
06
frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
07
The slide uses a hub-and-spoke diagram to illustrate data integration and a 2x2 matrix to represent the platform's core capabilities.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
08
The slide uses a comparative framework to contrast industry standards with AI-enhanced outcomes across two distinct R&D phases.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
09
The slide uses a process flow diagram to illustrate the transformation of raw data into actionable scientific insights.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
10
The slide uses a comparison framework to highlight efficiency gains in drug discovery.compare_peers
Open slide detail
11
The chart segments companies by the number of commercialized products and compares their IND filing rates (2015-2020) against BenevolentAI's projected targets.compare_peers
Open slide detail
12
The slide uses a process flow diagram to illustrate how the platform generates assets which are then either developed in-house or out-licensed, alongside secondpresent_solution
Open slide detail
13
The chart uses a horizontal bar format to represent progress through clinical phases. Several programs are marked with AstraZeneca partnership dates.show_traction
Open slide detail
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.show_traction
Open slide detail
15
The slide uses a list-based framework to demonstrate the 'Novel, Rapid, Effective' nature of their AI-driven discovery process.show_traction
Open slide detail
16
summarize
Open slide detail
17
The table presents financial data in thousands of pounds (£'000) for the six months ended June 30th.analyze_data
Open slide detailBeat · Financials
18
The slide uses a hub-and-spoke diagram to link the company to its five strategic capital allocation pillars.plan_implementation
Open slide detailBeat · Financials
19
The slide contrasts the market problem (left) with the proposed solution/mechanism (right).frame_problem
Open slide detail
20
Includes explicit caveats regarding the small sample size and short duration of the Phase Ib study.analyze_data
Open slide detail
21
Includes a breakdown of UC patient severity segments (64%, 31%, 5%).frame_problem
Open slide detail
22
The slide uses a process diagram to explain the experimental setup (biopsy -> organ culture -> measurement) followed by bar charts showing efficacy.present_solution
Open slide detail
23
The slide uses a timeline at the top and a three-column process framework at the bottom.plan_implementation
Open slide detail
24
summarize
Open slide detail
25
appendix
Open slide detail
26
summarize
Open slide detail
27
plan_implementation
Open slide detail
28
The slide explains the impact of one-off business combination costs on the reported operating loss for the six months ended 30 June 2022.analyze_data
Open slide detail
29
The slide provides specific context for non-cash adjustments and working capital movements.analyze_data
Open slide detail
30
The slide uses two charts to show market growth and pipeline maturity.argue_timing
Open slide detailBeat · MarketLoop · Why Now
31
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, etc.) to specific therapeutic area business models.present_solution
Open slide detail
32
The slide uses a 2x2 matrix to map specific industry players against two strategic dimensions.present_framework
Open slide detail
33
Uses a 2x2 matrix to represent the platform components.present_solution
Open slide detail
34
The slide uses a process flow diagram to illustrate data ingestion, NLP-based extraction, and the resulting knowledge graph.present_solution
Open slide detail
35
show_traction
Open slide detail
36
The slide uses a process flow framework to detail the specific steps in the Target ID phase, including TPA (Target Progressibility Assessment).present_solution
Open slide detail
37
The slide uses a vertical timeline on the left to anchor the four steps: Tech Approach, Predict, Triage, and Assay.present_solution
Open slide detail
38
The central circular diagram represents a feedback loop between lab capabilities and data integration.present_solution
Open slide detail
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.show_traction
Open slide detail
40
The slide outlines a clinical trial process flow with specific durations and patient ratios.plan_implementation
Open slide detail
41
Includes multiple charts showing inhibition of cytokines and reduction of inflammation.present_solution
Open slide detail
42
The diagram uses a process flow to show where BEN-2293 fits into the treatment landscape relative to existing therapies.present_solution
Open slide detail
43
The slide uses a process flow framework to explain the drug discovery pipeline.plan_implementation
Open slide detail
44
Includes a biological pathway diagram, a volcano plot for differential expression, and a tissue-specific RNAseq expression chart.analyze_data
Open slide detail
45
The slide uses a causal chain framework to link PDE10 inhibition to therapeutic outcomes.present_solution
Open slide detail
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.compare_peers
Open slide detail